Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 31Gynecologic 8CNS 7Other solid neoplasm 5Genitourinary 5Gastrointestinal 5Thoracic 4Dermatologic 4Lymphoid 3Head & Neck 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Endocrine 1Breast 1

Conditions

Neuroendocrine Tumors 169Carcinoma, Neuroendocrine 73Thyroid Neoplasms 52Pheochromocytoma 45Thyroid Carcinoma, Anaplastic 42Thyroid Cancer, Papillary 42Adrenocortical Carcinoma 40Carcinoid Tumor 39Paraganglioma 35Adenocarcinoma, Follicular 33Neoplasm Metastasis 29Neoplasms 28Somatostatinoma 26Adenoma, Islet Cell 26Insulinoma 22Carcinoma, Medullary 22Carcinoma, Islet Cell 22Pancreatic Neoplasms 21Pituitary Neoplasms 20Sarcoma 19Glucagonoma 19Gastrinoma 19Gastro-enteropancreatic neuroendocrine tumor 16Head and Neck Neoplasms 15Colorectal Neoplasms 14Multiple Endocrine Neoplasia Type 1 13Neuroblastoma 12Carcinoma, Renal Cell 12Carcinoma, Non-Small-Cell Lung 12Vipoma 11

Interventions

3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Chondrosarcoma × Endocrine × Clear all
NCT01560260 2018-09-21

Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors

National Cancer Institute (NCI)

Phase 2 Completed
20 enrolled 15 charts
CNSEndocrineGastrointestinalSarcoma

Chondrosarcoma, Paraganglioma, Gastrointestinal Stromal Tumors, Carney Complex

Data powered by HemOnc (CC BY 4.0) Colophon âš¡